PATENT CLAIM ANALYSIS

Application Number: 16284349
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-08
Patent Classification: ["514", "334000"]

Abstract:
Disclosed herein are compounds effective for activation of Tie-2 and inhibition of HPTP-beta. The compounds can provide effective therapy for conditions associated with diabetic nephropathy, for example, diabetic nephropathy resulting from hyperglycemia, kidney hyperfiltration, renal injury, glycation products, and cytokine activation.

Claim (Index 6):
The method of  claim 5 , wherein:\n Aryl 2  is a substituted thiazole moiety; L 2  together with the nitrogen atom to which L 2  is bound forms a carbamate linkage; R a  is alkyl, which is substituted or unsubstituted; R b  is arylalkyl, which is substituted or unsubstituted; R c  is H; and R d  is H.

Metadata:
- Claim Count in Document: 66.0
- Percentile: 99.0
- Lexical Diversity: 1.44118
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14657276', '13999670', '10850967', '13180144', '10474331']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8011185857920962
- 35 USC 102 Novelty (BERT): 0.5274372766683425
- Combined Prediction Score: 0.7737504548797208
- Mean Citation Score: 289.11545399999994
- Max Citation Score: 344.46616
- Similarity Product: 259.15549248682976

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test